Carolyn Bertozzi

Directeur/Membre du Conseil chez ELI LILLY AND COMPANY Fortune : 3 M $ au 31/05/2026

Profil

Carolyn R.
Bertozzi founded Redwood Bioscience, Inc. in 2008, TwoStep Therapeutics, Inc. in 2024, Palleon Pharmaceuticals, Inc. in 2015, Venn Biosciences Corp.
in 2017, Lycia Therapeutics, Inc. in 2019, and Enable Biosciences, Inc. in 2016, where she worked as Chairman.
Dr. Bertozzi also founded Firefly Bio, Inc. Dr. Bertozzi also currently works at Grace Science Foundation, as Director, OmniAb Operations, Inc., as Independent Director, OmniAb, Inc., as Independent Director from 2022, Stanford Chem-H, as Director from 2021, Xaira Therapeutics, Inc., as Director, Eli Lilly & Co., as Independent Director from 2025, Stanford University, as Professor, American Chemical Society, as Member, The Royal Society, as Member, Howard Hughes Medical Institute, Inc., as Professor, National Academy of Sciences, as Member, American Academy of Arts & Sciences, as Member, National Academy of Medicine (United States), as Member, American Society for Biochemistry & Molecular Biology, Inc., as Member, Accademia Nazionale dei Lincei, as Member, and National Academy of Inventors, as Member.
Dr. Bertozzi also formerly worked at Eli Lilly & Co., as Independent Director from 2017 to 2021, Lawrence Berkeley National Laboratory, as Director-Molecular Foundry, The Broad Institute, Inc., as Director, Catalent, Inc., as Director, Molecular Foundry, as Director, Alnylam Pharmaceuticals, Inc., as Independent Director from 2023 to 2025, and the University of California, Berkeley, as Professor from 1996 to 2015.
Dr. Bertozzi received her doctorate degree in 1993 from the University of California, Berkeley.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ELI LILLY AND COMPANY 0 %	25/02/2026	2 000 ( 0 % )	2 M $	31/05/2026
OMNIAB, INC. 0,08 %	23/04/2026	113 308 ( 0,08 % )	305 932 $	31/05/2026
ALNYLAM PHARMACEUTICALS, INC 0 %	08/05/2025	775 ( 0 % )	234 035 $	31/05/2026

Postes actifs de Carolyn Bertozzi

Sociétés	Poste	Début
OMNIAB, INC.	Directeur/Membre du Conseil	01/11/2022
ELI LILLY AND COMPANY	Directeur/Membre du Conseil	08/12/2025
Stanford Chem-H	Directeur/Membre du Conseil	01/01/2021
Accademia Nazionale dei Lincei	Corporate Officer/Principal	-
The Royal Society	Corporate Officer/Principal	-
National Academy of Inventors	Corporate Officer/Principal	-
OmniAb Operations, Inc.	Directeur/Membre du Conseil	-
Howard Hughes Medical Institute, Inc.	Corporate Officer/Principal	-
Grace Science Foundation	Directeur/Membre du Conseil	-

Anciens postes connus de Carolyn Bertozzi

Sociétés	Poste	Fin
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░ ░░░░░ ░░░ ░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░	░░░░░░░░░	-